Table 3.

Multivariable Associations Between Provider Beliefs and Demographics and Likelihood of Offering Standard Cancer Treatment to HIV-Infected Patients

Factor	Adjusted OR*	95% CI
1: Perceptions†	0.92	0.80 to 1.07
2: Comfort level discussing adverse effects and prognosis‡	1.52	1.12 to 2.07
3: Toxicity and efficacy concerns§	0.67	0.53 to 0.85

NOTE. Patients with missing data were excluded from analysis.

Abbreviation: OR, odds ratio.

^*ORs adjusted for specialty, sex, age, time since training, geographic region, residence in high-prevalence state, No. of patients without insurance, No. of patients with Medicare or Ryan White insurance, size of group practice, and factors 1 to 3.

^†Factor 1 includes following perceptions: HIV-infected patients are less likely to adhere to cancer treatment, are more likely to be uninsured or underinsured, have more-advanced cancer stage, have worse performance status, and have more-severe comorbidities.

^‡Factor 2 includes following perception: personal comfort level with discussion of cancer adverse effects and prognosis in HIV-infected patients.

^§Factor 3 includes following perceptions: HIV-infected patients are more likely to experience toxicity from chemotherapy and radiation therapy, and cancer treatment is less efficacious in HIV-infected patients.